Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

Clinical trial NCT01809262 · COMPLETED

Trial details

NCT number: NCT01809262
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2005-12-01
Primary completion: 2006-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.